{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:08:54Z","timestamp":1791475734732,"version":"4.3.4"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009382","name":"Solve ME\/CFS Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Myalgic encephalomyelitis or chronic fatigue syndrome (ME\/CFS) affects approximately 1% of the general population. It is a chronic, disabling, multi-system disease for which there is no effective treatment. This is probably related to the limited knowledge about its origin. Here, we summarized the current knowledge about the pathogenesis of ME\/CFS and revisit the immunopathobiology of Epstein-Barr virus (EBV) infection. Given the similarities between EBV-associated autoimmune diseases and cancer in terms of poor T cell surveillance of cells with EBV latency, expanded EBV-infected cells in peripheral blood and increased antibodies against EBV, we hypothesize that there could be a common etiology generated by cells with EBV latency that escape immune surveillance. Albeit inconclusive, multiple studies in patients with ME\/CFS have suggested an altered cellular immunity and augmented Th2 response that could result from mechanisms of evasion to some pathogens such as EBV, which has been identified as a risk factor in a subset of ME\/CFS patients. Namely, cells with latency may evade the immune system in individuals with genetic predisposition to develop ME\/CFS and in consequence, there could be poor CD4 T cell immunity to mitogens and other specific antigens, as it has been described in some individuals. Ultimately, we hypothesize that within ME\/CFS there is a subgroup of patients with DRB1 and DQB1 alleles that could confer greater susceptibility to EBV, where immune evasion mechanisms generated by cells with latency induce immunodeficiency. Accordingly, we propose new endeavors to investigate if anti-EBV therapies could be effective in selected ME\/CFS patients.<\/jats:p>","DOI":"10.3389\/fimmu.2021.656797","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T01:50:50Z","timestamp":1636941050000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":90,"title":["Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome"],"prefix":"10.3389","volume":"12","author":[{"given":"Manuel","family":"Ruiz-Pablos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Montero-Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aintzane","family":"Zabaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/diagnostics9030091","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: A Comprehensive Review","volume":"9","author":"Cortes Rivera","year":"2019","journal-title":"Diagnostics"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.08.003","article-title":"Immunological Aspects of Chronic Fatigue Syndrome","volume":"8","author":"Lorusso","year":"2009","journal-title":"Autoimmun Rev Elsevier"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00059","article-title":"Epstein-Barr Virus Induced Gene-2 Upregulation Identifies a Particular Subtype of Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis","volume":"7","author":"Kerr","year":"2019","journal-title":"Front Pediatrics Front Media SA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12916-014-0167-5","article-title":"Two Age Peaks in the Incidence of Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis: A Population-Based Registry Study From Norway 2008-2012","volume":"12","author":"Bakken","year":"2014","journal-title":"BMC Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/0141076817702530","article-title":"Trends in the Incidence of Chronic Fatigue Syndrome and Fibromyalgia in the UK, 2001\u20132013: A Clinical Practice Research Datalink Study","volume":"110","author":"Collin","year":"2017","journal-title":"J R Soc Med"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1111\/j.1751-9861.2008.00033.x","article-title":"The Associations Between Basal Salivary Cortisol and Illness Symptomatology in Chronic Fatigue Syndrome","volume":"13","author":"Torres-Harding","year":"2008","journal-title":"J Appl Biobehav Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsycho.2011.02.002","article-title":"Meta-Analysis and Meta-Regression of Hypothalamic-Pituitary-Adrenal Axis Activity in Functional Somatic Disorders","volume":"87","author":"Tak","year":"2011","journal-title":"Biol Psychol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0170-2","article-title":"Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)\/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways","volume":"54","author":"Morris","year":"2017","journal-title":"Mol Neurobiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1300\/J092v13n01_02","article-title":"Prevalence of Chronic Fatigue Syndrome and Chronic Fatigue Within Families of CFS Patients","volume":"13","author":"Underhill","year":"2011","journal-title":"J Chronic Fatigue Syndr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/00041444-200109000-00003","article-title":"A Family History Study of Chronic Fatigue Syndrome","volume":"11","author":"Walsh","year":"2001","journal-title":"Psychiatr Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa169","article-title":"Genetic Risk Factors of ME\/CFS: A Critical Review","volume":"29","author":"Dibble","year":"2020","journal-title":"Hum Mol Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2015.10.011","article-title":"Myalgic Encephalomyelitis, Chronic Fatigue Syndrome: An Infectious Disease","volume":"85","author":"Underhill","year":"2015","journal-title":"Med Hypotheses"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00012","article-title":"Onset Patterns and Course of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"7","author":"Chu","year":"2019","journal-title":"Front Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-11-62","article-title":"Evidence for a Heritable Predisposition to Chronic Fatigue Syndrome","volume":"11","author":"Albright","year":"2011","journal-title":"BMC Neurol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI132185","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome Patients Exhibit Altered T Cell Metabolism and Cytokine Associations","volume":"130","author":"Mandarano","year":"2020","journal-title":"J Clin Invest"},{"key":"B16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1479-5876-9-81","article-title":"Immunological Abnormalities as Potential Biomarkers in Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis","volume":"9","author":"Brenu","year":"2011","journal-title":"J Transl Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/cei.12882","article-title":"Impaired Calcium Mobilization in Natural Killer Cells From Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis Patients Is Associated With Transient Receptor Potential Melastatin 3 Ion Channels","volume":"187","author":"Nguyen","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/TACG.S99405","article-title":"Natural Killer Cells and Single Nucleotide Polymorphisms of Specific Ion Channels and Receptor Genes in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"9","author":"Marshall-Gradisnik","year":"2016","journal-title":"Appl Clin Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.01.009","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome \u2013 Evidence for an Autoimmune Disease","volume":"17","author":"Sotzny","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2004.022681","article-title":"Association of Chronic Fatigue Syndrome With Human Leucocyte Antigen Class II Alleles","volume":"58","author":"Smith","year":"2005","journal-title":"J Clin Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1038\/s41598-020-62157-x","article-title":"Human Leukocyte Antigen Alleles Associated With Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS)","volume":"10","author":"Lande","year":"2020","journal-title":"Sci Rep"},{"key":"B22","article-title":"Association between HLA Class II Antigens and the Chronic Fatigue Immune Dysfunction Syndrome","volume":"18","author":"Keller","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2370.2001.00235.x","article-title":"Lack of Association Between HLA Genotype and Chronic Fatigue Syndrome","volume":"28","author":"Underhill","year":"2001","journal-title":"Eur J Immunogenet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2011.02428.x","article-title":"Myalgic Encephalomyelitis: International Consensus Criteria","volume":"270","author":"Carruthers","year":"2011","journal-title":"J Internal Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198411000-00007","article-title":"Chronic Mononucleosis Syndrome","volume":"77","author":"Dubois","year":"1984","journal-title":"South Med J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1086\/513627","article-title":"Chronic Parvovirus B19 Infection Resulting in Chronic Fatigue Syndrome: Case History and Review","volume":"24","author":"Jacobson","year":"1997","journal-title":"Clin Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04799.x","article-title":"Infection, Vaccination, and Autoantibodies in Chronic Fatigue Syndrome, Cause or Coincidence","volume":"1173","author":"Ortega-Hernandez","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25744","article-title":"Cytomegalovirus, Epstein-Barr Virus, and Human Herpesvirus-6 Infections in Patients With Myalgic \u0415ncephalomyelitis\/Chronic Fatigue Syndrome","volume":"92","author":"Shikova","year":"2020","journal-title":"J Med Virol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.2000006","article-title":"Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"4","author":"Schreiner","year":"2020","journal-title":"ImmunoHorizons"},{"key":"B30","first-page":"908","article-title":"The Enterovirus Theory of Disease Etiology in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: A Critical Review","author":"O\u2019Neal","year":"2021","journal-title":"Front Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1515\/reveh-2015-0026","article-title":"Review of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: An Evidence-Based Approach to Diagnosis and Management by Clinicians","volume":"30","author":"Bested","year":"2015","journal-title":"Rev Environ Health Walter Gruyter GmbH"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens1020156","article-title":"Epstein-Barr Virus Sequence Variation\u2014Biology and Disease","volume":"1","author":"Tzellos","year":"2012","journal-title":"Pathogens"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4941783","DOI":"10.1155\/2016\/4941783","article-title":"Epstein-Barr Virus and Its Association With Oral Hairy Leukoplakia: A Short Review","volume":"2016","author":"Khammissa","year":"2016","journal-title":"Int J Dentistry Hindawi Publishing Corporation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"535738","DOI":"10.1155\/2013\/535738","article-title":"Epstein-Barr Virus in Systemic Autoimmune Diseases","volume":"2013","author":"Draborg","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8496-1","article-title":"The Interplay Between Epstein-Barr Virus and B Lymphocytes: Implications for Infection, Immunity, and Disease","volume":"58","author":"Hatton","year":"2014","journal-title":"Immunol Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002697","article-title":"Epstein-Barr Virus Infection of Na\u00efve B Cells In Vitro Frequently Selects Clones With Mutated Immunoglobulin Genotypes: Implications for Virus Biology. Sugden B, Editor","volume":"8","author":"Heath","year":"2012","journal-title":"PloS Pathog"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2034960100","article-title":"Interference With T Cell Receptor-HLA-DR Interactions by Epstein-Barr Virus Gp42 Results in Reduced T Helper Cell Recognition","volume":"100","author":"Ressing","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/ijms19010317","article-title":"Human MHC-II With Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands\u2014Relation to Rheumatoid Arthritis","volume":"19","author":"Trier","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.8.5557-5563.1996","article-title":"The Extracellular Domain of the Epstein-Barr Virus BZLF2 Protein Binds the HLA-DR Beta Chain and Inhibits Antigen Presentation","volume":"70","author":"Spriggs","year":"1996","journal-title":"J Virol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.2.841-852.2005","article-title":"Epstein-Barr Virus Gp42 Is Posttranslationally Modified To Produce Soluble Gp42 That Mediates HLA Class II Immune Evasion","volume":"79","author":"Ressing","year":"2005","journal-title":"J Virol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-274076","article-title":"Expansion of EBNA1-Specific Effector T Cells in Posttransplantation Lymphoproliferative Disorders","volume":"116","author":"Jones","year":"2010","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24014","article-title":"Children With Endemic Burkitt Lymphoma Are Deficient in EBNA1-Specific IFN-\u03b3 T Cell Responses","volume":"124","author":"Moormann","year":"2009","journal-title":"Int J Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines3030224","article-title":"High Levels of IL-10 and CD4+CD25hi+ Treg Cells in Endemic Burkitt\u2019s Lymphoma Patients","volume":"3","author":"Futagbi","year":"2015","journal-title":"Biomedicines"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23845","article-title":"Patients With Epstein Barr Virus-Positive Lymphomas Have Decreased CD4 + T-Cell Responses to the Viral Nuclear Antigen 1","volume":"123","author":"Heller","year":"2008","journal-title":"Int J Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0432","article-title":"Loss of EBNA1-Specific Memory CD4+ and CD8+ T Cells in HIV-Infected Patients Progressing to AIDS-Related Non-Hodgkin Lymphoma","volume":"106","author":"Piriou","year":"2005","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0909448107","article-title":"Nuclear Location of an Endogenously Expressed Antigen, EBNA1, Restricts Access to Macroautophagy and the Range of CD4 Epitope Display","volume":"107","author":"Leung","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00251-017-1017-3","article-title":"A Genomic Perspective on HLA Evolution","volume":"70","author":"Meyer","year":"2018","journal-title":"Immunogenetics Springer Verlag"},{"key":"B48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1880-6805-33-14","article-title":"A Human-Specific Allelic Group of the MHC DRB1 Gene in Primates","volume":"33","author":"Yasukochi","year":"2014","journal-title":"J Physiol Anthropol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1999.tb01403.x","article-title":"Major Histocompatibility Complex Class II Polymorphisms in Primates","volume":"167","author":"Bontrop","year":"1999","journal-title":"Immunol Rev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.017251-0","article-title":"Lymphocryptovirus Phylogeny and the Origins of Epstein-Barr Virus","volume":"91","author":"Ehlers","year":"2010","journal-title":"J Gen Virol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.13.7655-7662.2003","article-title":"Mutational Analysis of the HLA Class II Interaction With Epstein-Barr Virus Glycoprotein 42","volume":"77","author":"McShane","year":"2003","journal-title":"J Virol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(02)00465-3","article-title":"Structure of the Epstein-Barr Virus Gp42 Protein Bound to the MHC Class II Receptor HLA-Dr1","volume":"9","author":"Mullen","year":"2002","journal-title":"Mol Cell"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.160171697","article-title":"Coreceptor Restriction Within the HLA-DQ Locus for Epstein-Barr Virus Infection","volume":"97","author":"Haan","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-22834-1_11","article-title":"T-Cell Responses to EBV","author":"Hislop","year":"2015","journal-title":"Curr Topics Microbiol Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq159","article-title":"Epstein\u2013Barr Virus in Bone Marrow of Rheumatoid Arthritis Patients Predicts Response to Rituximab Treatment","volume":"49","author":"Magnusson","year":"2010","journal-title":"Rheumatology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2006.08.007","article-title":"Viral Causes of Arthritis","volume":"20","author":"Franssila","year":"2006","journal-title":"Best Pract Research: Clin Rheumatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/BOR.0000000000000289","article-title":"How Compelling Are the Data for Epstein\u2013Barr Virus Being a Trigger for Systemic Lupus and Other Autoimmune Diseases","volume":"28","author":"Draborg","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"370516","DOI":"10.1155\/2012\/370516","article-title":"Epstein-Barr Virus and Systemic Lupus Erythematosus","volume":"2012","author":"Draborg","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study","volume":"286","author":"Ascherio","year":"2001","journal-title":"J Am Med Assoc"},{"key":"B60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/1673-5374.245462","article-title":"The Role of Epstein-Barr Virus in Multiple Sclerosis: From Molecular Pathophysiology to In Vivo Imaging","volume":"14","author":"Guan","year":"2019","journal-title":"Neural Regener Res"},{"key":"B61","doi-asserted-by":"crossref","first-page":"18083","DOI":"10.1038\/srep18083","article-title":"A Meta-Analysis of Interaction Between Epstein-Barr Virus and HLA-DRB1\u22171501 on Risk of Multiple Sclerosis","volume":"5","author":"Xiao","year":"2015","journal-title":"Sci Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20731","article-title":"Epstein-Barr Virus in Tumor-Infiltrating B Cells of Myasthenia Gravis Thymoma: An Innocent Bystander or an Autoimmunity Mediator","volume":"8","author":"Cavalcante","year":"2017","journal-title":"Oncotarget"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/j.2040-1124.2010.00061.x","article-title":"Fulminant Type\u20031 Diabetes Mellitus Associated With a Reactivation of Epstein-Barr Virus That Developed in the Course of Chemotherapy of Multiple Myeloma","volume":"1","author":"Fujiya","year":"2010","journal-title":"J Diabetes Investig"},{"key":"B64","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","article-title":"Transcription Factors Operate Across Disease Loci, With EBNA2 Implicated in Autoimmunity","volume":"50","author":"Harley","year":"2018","journal-title":"Nat Genet"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1157\/13085286","article-title":"Infecci\u00f3n Por El Virus De Epstein-Barr Y Enfermedad De Graves-Basedow: \u00bfSimple Casualidad O Algo M\u00e1s","volume":"126","author":"Stiefel","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.5603\/EP.2015.0020","article-title":"The Role of Epstein-Barr Virus Infection in the Development of Autoimmune Thyroid Diseases","volume":"66","author":"Janegova","year":"2015","journal-title":"Endokrynol Pol"},{"key":"B67","first-page":"39","article-title":"Virus De Epstein-Barr Y Su Relaci\u00f3n Con El Desarrollo De Enfermedades Linfoproliferativas","volume":"9","author":"Beltramino","year":"2005","journal-title":"Hematolog\u00eda"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-71775-4","article-title":"High MHC-II Expression in Epstein\u2013Barr Virus-Associated Gastric Cancers Suggests That Tumor Cells Serve an Important Role in Antigen Presentation","volume":"10","author":"Ghasemi","year":"2020","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.5.2451-2454.2000","article-title":"Epstein-Barr Virus Entry Utilizing HLA-DP or HLA-DQ as a Coreceptor","volume":"74","author":"Haan","year":"2000","journal-title":"J Virol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.03.022","article-title":"Detection of Active Epstein\u2013Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease","volume":"14","author":"Perfetti","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1038\/cti.2014.25","article-title":"Epstein\u2013Barr Virus and Multiple Sclerosis: Potential Opportunities for Immunotherapy","volume":"3","author":"Pender","year":"2014","journal-title":"Clin Transl Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/BF00201470","article-title":"Reactivation of Epstein-Barr Virus in Sj\u00f6gren\u2019s Syndrome","volume":"13","author":"Fox","year":"1991","journal-title":"Springer Semin Immunopathol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.19082\/2181","article-title":"Detection of Epstein-Barr Virus in Synovial Fluid of Rheumatoid Arthritis Patients","volume":"8","author":"Mahabadi","year":"2016","journal-title":"Electron Physician"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2007.05.001","article-title":"Pathophysiological Links Between Rheumatoid Arthritis and the Epstein-Barr Virus: An Update","volume":"74","author":"Toussirot","year":"2007","journal-title":"Joint Bone Spine Elsevier Masson;"},{"key":"B75","article-title":"Epstein-Barr Virus Dutpase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"41","author":"PhD","year":"2019","journal-title":"Clin Ther"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24810","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome and Gulf War Illness Patients Exhibit Increased Humoral Responses to the Herpesviruses-Encoded Dutpase: Implications in Disease Pathophysiology","volume":"89","author":"Halpin","year":"2017","journal-title":"J Med Virol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"85387","DOI":"10.1371\/journal.pone.0085387","article-title":"Deficient EBV-Specific B- and T-Cell Response in Patients With Chronic Fatigue Syndrome","volume":"9","author":"Loebel","year":"2014","journal-title":"PloS One"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.31.313","article-title":"Studies on the Relationship Between Chronic Fatigue Syndrome and Epstein-Barr Virus in Japan","volume":"31","author":"Kawai","year":"1992","journal-title":"Intern Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1159\/000150450","article-title":"Antibody Responses to Epstein-Barr Virus, Human Herpesvirus 6 and Human Herpesvirus 7 in Patients With Chronic Fatigue Syndrome","volume":"38","author":"Sairenji","year":"1995","journal-title":"Intervirology"},{"key":"B80","article-title":"IgM Serum Antibodies to Epstein-Barr Virus Are Uniquely Present in a Subset of Patients With the Chronic Fatigue Syndrome","volume":"18","author":"Lerner","year":"2004","journal-title":"In Vivo (Brooklyn)"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e0179124","DOI":"10.1371\/journal.pone.0179124","article-title":"Serological Profiling of the EBV Immune Response in Chronic Fatigue Syndrome Using a Peptide Microarray","volume":"12","author":"Loebel","year":"2017","journal-title":"PloS One"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom11020185","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back","volume":"11","author":"A","year":"2021","journal-title":"Biomolecules"},{"key":"B83","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12967-018-1644-y","article-title":"Chronic Viral Infections in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS)","volume":"16","author":"Rasa","year":"2018","journal-title":"J Transl Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21873","article-title":"Serological and Virological Investigation of the Role of the Herpesviruses EBV, CMV and HHV-6 in Post-Infective Fatigue Syndrome","volume":"82","author":"Cameron","year":"2010","journal-title":"J Med Virol"},{"key":"B85","first-page":"46","article-title":"Chronic Fatigue Syndrome and Herpesviruses: The Fading Evidence","volume":"7","author":"Soto","year":"2000","journal-title":"Herpes"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.2.1296-1307.2005","article-title":"Terminal Differentiation Into Plasma Cells Initiates the Replicative Cycle of Epstein-Barr Virus In Vivo","volume":"79","author":"Laichalk","year":"2005","journal-title":"J Virol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.78.10.4983-4992.2004","article-title":"The BRRF1 Early Gene of Epstein-Barr Virus Encodes a Transcription Factor That Enhances Induction of Lytic Infection by BRLF1","volume":"78","author":"Hong","year":"2004","journal-title":"J Virol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2007.04.007","article-title":"Longitudinal Analysis of Pro- and Anti-Inflammatory Cytokine Production in Severely Fatigued Adolescents","volume":"21","author":"ter Wolbeek","year":"2007","journal-title":"Brain Behav Immun"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02560-0","article-title":"Cytokine Profiling of Extracellular Vesicles Isolated From Plasma in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: A Pilot Study","volume":"18","author":"Giloteaux","year":"2020","journal-title":"J Transl Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12967-019-1948-6","article-title":"The Clinical Value of Cytokines in Chronic Fatigue Syndrome","volume":"17","author":"Yang","year":"2019","journal-title":"J Transl Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.bbi.2010.04.012","article-title":"A Formal Analysis of Cytokine Networks in Chronic Fatigue Syndrome","volume":"24","author":"Broderick","year":"2010","journal-title":"Brain Behav Immun"},{"key":"B92","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1743-7075-7-79","article-title":"Gut Inflammation in Chronic Fatigue Syndrome","volume":"7","author":"Lakhan","year":"2010","journal-title":"Nutr Metab"},{"key":"B93","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40168-016-0171-4","article-title":"Reduced Diversity and Altered Composition of the Gut Microbiome in Individuals With Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"4","author":"Giloteaux","year":"2016","journal-title":"Microbiome"},{"key":"B94","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40168-017-0261-y","article-title":"Fecal Metagenomic Profiles in Subgroups of Patients With Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"5","author":"Nagy-Szakal","year":"2017","journal-title":"Microbiome"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3956(96)00063-5","article-title":"Cytokine Production by Adherent and Non-Adherent Mononuclear Cells in Chronic Fatigue Syndrome","volume":"31","author":"Gupta","year":"1997","journal-title":"J Psychiatr Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/s0091-6749(98)70090-9","article-title":"Chronic Fatigue Syndrome: Identification of Distinct Subgroups on the Basis of Allergy and Psychologic Variables","volume":"102","author":"Borish","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12883-019-1433-0","article-title":"A Systematic Review of Cytokines in Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis\/Systemic Exertion Intolerance Disease (CFS\/ME\/SEID)","volume":"19","author":"Corbitt","year":"2019","journal-title":"BMC Neurol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2015.07.004","article-title":"Chronic Fatigue Syndrome and Circulating Cytokines: A Systematic Review","volume":"50","author":"Blundell","year":"2015","journal-title":"Brain Behav Immun"},{"key":"B99","doi-asserted-by":"publisher","first-page":"104578","DOI":"10.1016\/j.psyneuen.2019.104578","article-title":"The Role of Low-Grade Inflammation in ME\/CFS (Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome) - Associations With Symptoms","volume":"113","author":"Jonsj\u00f6","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129898","article-title":"B-Lymphocyte Depletion in Myalgic Encephalopathy\/ Chronic Fatigue Syndrome. An Open-Label Phase II Study With Rituximab Maintenance Treatment. Van Der Feltz-Cornelis C, Editor","volume":"10","author":"Fluge","year":"2015","journal-title":"PloS One"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e000755","DOI":"10.1161\/JAHA.113.000755","article-title":"Autoimmune Basis for Postural Tachycardia Syndrome","volume":"3","author":"Li","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.11.5954","article-title":"Characterization of CD4 + CTLs Ex Vivo","volume":"168","author":"Appay","year":"2002","journal-title":"J Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1038\/cti.2015.13","article-title":"Granzyme B Mediated Function of Parvovirus B19-Specific CD4+ T Cells","volume":"4","author":"Kumar","year":"2015","journal-title":"Clin Transl Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(00)01699-6","article-title":"Viral Mechanisms of Immune Evasion","volume":"21","author":"Alcami","year":"2000","journal-title":"Immunol Today"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00197","article-title":"Fighting Viral Infections and Virus-Driven Tumors With Cytotoxic CD4+ T Cells","volume":"8","author":"Muraro","year":"2017","journal-title":"Front Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1080\/07399330600803766","article-title":"Causes of Death Among Patients With Chronic Fatigue Syndrome","volume":"27","author":"Jason","year":"2006","journal-title":"Health Care Women Int"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.656692\/full","article-title":"Salivary DNA Loads for Human Herpesviruses 6 and 7 Are Correlated With Disease Phenotype in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","author":"Lee","year":"2021","journal-title":"Front Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27612","article-title":"Chronic Fatigue Syndrome and Subsequent Risk of Cancer Among Elderly US Adults","volume":"118","author":"Chang","year":"2012","journal-title":"Cancer"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3999(99)00013-6","article-title":"Chronic Fatigue Syndrome in Private Practice Psychiatry: Family History of Physical and Mental Health","volume":"47","author":"Endicott","year":"1999","journal-title":"J Psychosom Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00229","article-title":"Infection Elicited Autoimmunity and Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: An Explanatory Model","volume":"9","author":"Blomberg","year":"2018","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2019.04.040","article-title":"Clinical Symptoms and Markers of Disease Mechanisms in Adolescent Chronic Fatigue Following Epstein-Barr Virus Infection: An Exploratory Cross-Sectional Study","volume":"80","author":"Kristiansen","year":"2019","journal-title":"Brain Behav Immun"},{"key":"B112","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/lupus-2014-000015","article-title":"Reduced Response to Epstein-Barr Virus Antigens by T-Cells in Systemic Lupus Erythematosus Patients","volume":"1","author":"Draborg","year":"2014","journal-title":"Lupus Sci Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1038\/cti.2016.87","article-title":"Defective T-Cell Control of Epstein\u2013Barr Virus Infection in Multiple Sclerosis","volume":"6","author":"Pender","year":"2017","journal-title":"Clin Transl Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2008.09.007","article-title":"Epstein-Barr Virus in Autoimmune Diseases","volume":"22","author":"Toussirot","year":"2008","journal-title":"Best Pract Research: Clin Rheumatol Bailli\u00e8re Tindall"},{"key":"B115","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.clinthera.2019.02.011","article-title":"Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-Based Commentary","volume":"41","author":"Richman","year":"2019","journal-title":"Clin Ther"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1451","article-title":"B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"170","author":"Fluge","year":"2019","journal-title":"Ann Intern Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026358","article-title":"Benefit From B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study. Reindl M, Editor","volume":"6","author":"Fluge","year":"2011","journal-title":"PloS One"},{"key":"B118","article-title":"Valacyclovir Treatment in Epstein-Barr Virus Subset Chronic Fatigue Syndrome: Thirty-Six Months Follow-Up","volume":"21","author":"Lerner","year":"2007","journal-title":"In Vivo (Brooklyn)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23713","article-title":"Randomized Clinical Trial to Evaluate the Efficacy and Safety of Valganciclovir in a Subset of Patients With Chronic Fatigue Syndrome","volume":"85","author":"Montoya","year":"2013","journal-title":"J Med Virol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-143545","article-title":"How I Treat EBV Lymphoproliferation","volume":"114","author":"Heslop","year":"2009","journal-title":"Blood"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.01.017","article-title":"Preventing and Curing Multiple Sclerosis by Controlling Epstein-Barr Virus Infection","volume":"8","author":"Pender","year":"2009","journal-title":"Autoimmun Rev"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00693.x","article-title":"Cellular Immunity to Epstein-Barr Virus in Liver Transplant Recipients Treated With Rituximab for Post-Transplant Lymphoproliferative Disease","volume":"5","author":"Savoldo","year":"2005","journal-title":"Am J Transplant"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200109273451315","article-title":"Fatal Reactivation of Cytomegalovirus Infection After Use of Rituximab for a Post-Transplantation Lymphoproliferative Disorder","volume":"345","author":"Suzan","year":"2001","journal-title":"N Engl J Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.8.3740-3752.2001","article-title":"CD4+ T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation","volume":"75","author":"Nikiforow","year":"2001","journal-title":"J Virol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.11.8204-8208.1996","article-title":"A Simple Reverse Transcriptase PCR Assay to Distinguish EBNA1 Gene Transcripts Associated With Type I and II Latency From Those Arising During Induction of the Viral Lytic Cycle","volume":"70","author":"Schaefer","year":"1996","journal-title":"J Virol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20022058","article-title":"Characterization of the CD4+ T Cell Response to Epstein-Barr Virus During Primary and Persistent Infection","volume":"198","author":"Amyes","year":"2003","journal-title":"J Exp Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6064\/2012\/438204","article-title":"The Epstein-Barr Virus EBNA1 Protein","volume":"2012","author":"Frappier","year":"2012","journal-title":"Scientifica (Cairo)"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004126","article-title":"Epigenetic Reprogramming Sensitizes Immunologically Silent EBV+ Lymphomas to Virus-Directed Immunotherapy","volume":"135","author":"Dalton","year":"2020","journal-title":"Blood"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-1086-3","article-title":"Differential Down-Modulation of HLA Class I and II Molecule Expression on Human Tumor Cell Lines Upon In Vivo Transfer","volume":"60","author":"Turrini","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902850","article-title":"Virus-Specific Cytotoxic CD4 + T Cells for the Treatment of EBV-Related Tumors","volume":"184","author":"Merlo","year":"2010","journal-title":"J Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3390\/ijms18081606","article-title":"The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer","volume":"18","author":"Nishikawa","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24634","article-title":"Decitabine Inhibits Tumor Cell Proliferation and Up-Regulates E-Cadherin Expression in Epstein-Barr Virus-Associated Gastric Cancer","volume":"89","author":"Nakamura","year":"2017","journal-title":"J Med Virol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2013\/898730","article-title":"Parvovirus B19 Achievements and Challenges","volume":"2013","author":"Gallinella","year":"2013","journal-title":"ISRN Virol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"e33316","DOI":"10.1371\/journal.pone.0033316","article-title":"Parvovirus B19 DNA CpG Dinucleotide Methylation and Epigenetic Regulation of Viral Expression","volume":"7","author":"Bonvicini","year":"2012","journal-title":"PloS One"},{"key":"B135","doi-asserted-by":"publisher","first-page":"e25922","DOI":"10.1371\/journal.pone.0025922","article-title":"Epigenetic Control of Viral Life-Cycle by a DNA-Methylation Dependent Transcription Factor","volume":"6","author":"Flower","year":"2011","journal-title":"PloS One"},{"key":"B136","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/3-540-31181-5_5","article-title":"Epigenotypes of Latent Herpesvirus Genomes","volume":"310","author":"Minarovits","year":"2006","journal-title":"Curr Topics Microbiol Immunol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"ciaa1886","DOI":"10.1093\/cid\/ciaa1886","article-title":"Risks for Developing ME\/CFS in College Students Following Infectious Mononucleosis: A Prospective Cohort Study","author":"Jason","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.656797\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T01:51:03Z","timestamp":1636941063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.656797\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":137,"alternative-id":["10.3389\/fimmu.2021.656797"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.656797","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"article-number":"656797"}}